New report shows practices moving toward customized, long-term treatment strategies over one-off procedures.
Allergan Aesthetics released research indicating a market-wide shift toward personalized, long-term beauty strategies rather than transactional single-procedure visits. The data reflects what many practice owners already see: patients want a coherent plan—a combination of toxin, filler, and device work—tailored to their specific anatomy and goals, not just "Botox today, filler next month."
This trend has direct economics for your practice. Patients on a curated, multi-modality plan spend more per year, show higher retention, and generate more predictable revenue than those booking à la carte. It also raises the bar for clinical expertise: you need to assess a patient's full face, understand how toxin placement affects filler distribution, know which devices complement injectables, and communicate that strategy clearly.
Patients on multi-modality plans spend more and show higher retention.
The implication for practice owners is staffing and training. If your model is high-volume, single-service appointments, you're leaving money on the table. Allergan's data is essentially validating what premium practices have known: the practices winning on margin and retention are those offering integrated treatment planning, not just injections or devices in isolation.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
